Efficacy and safety of lifileucel, an autologous tumor-infiltrating lymphocyte cell therapy, and pembrolizumab in patients with immune checkpoint inhibitor–naive unresectable or metastatic melanoma: updated results from IOV-COM-202 Cohort 1A

• DOI: 10.1016/j.ejcskn.2025.100624
• Publication Date: 2025-04-03T11:48:27Z
• Authors: H. Gogas; A.J. Furness; S. Thomas; B. Doger de Spev...; Y.K. Hong; G.K. In; D. Lawrence; A. Garcia Castano; S. Haefliger; K. He; S. Lee; J. Martin-Liberal; T. Medina; F.G. Finckenstein; B. Gastman; J. Chou; R. Fiaz; M. Catlett; G. Chen; P. Terheyden